全文获取类型
收费全文 | 13786篇 |
免费 | 859篇 |
国内免费 | 170篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 137篇 |
妇产科学 | 187篇 |
基础医学 | 1288篇 |
口腔科学 | 118篇 |
临床医学 | 1604篇 |
内科学 | 675篇 |
皮肤病学 | 89篇 |
神经病学 | 6122篇 |
特种医学 | 198篇 |
外科学 | 680篇 |
综合类 | 1326篇 |
现状与发展 | 1篇 |
预防医学 | 557篇 |
眼科学 | 37篇 |
药学 | 1470篇 |
13篇 | |
中国医学 | 177篇 |
肿瘤学 | 104篇 |
出版年
2023年 | 135篇 |
2022年 | 243篇 |
2021年 | 384篇 |
2020年 | 413篇 |
2019年 | 571篇 |
2018年 | 501篇 |
2017年 | 413篇 |
2016年 | 464篇 |
2015年 | 420篇 |
2014年 | 779篇 |
2013年 | 993篇 |
2012年 | 733篇 |
2011年 | 858篇 |
2010年 | 730篇 |
2009年 | 669篇 |
2008年 | 750篇 |
2007年 | 707篇 |
2006年 | 669篇 |
2005年 | 502篇 |
2004年 | 399篇 |
2003年 | 364篇 |
2002年 | 317篇 |
2001年 | 227篇 |
2000年 | 176篇 |
1999年 | 166篇 |
1998年 | 170篇 |
1997年 | 164篇 |
1996年 | 146篇 |
1995年 | 126篇 |
1994年 | 111篇 |
1993年 | 84篇 |
1992年 | 89篇 |
1991年 | 73篇 |
1990年 | 79篇 |
1989年 | 55篇 |
1988年 | 52篇 |
1987年 | 67篇 |
1986年 | 59篇 |
1985年 | 129篇 |
1984年 | 134篇 |
1983年 | 84篇 |
1982年 | 86篇 |
1981年 | 87篇 |
1980年 | 75篇 |
1979年 | 75篇 |
1978年 | 55篇 |
1977年 | 51篇 |
1976年 | 44篇 |
1975年 | 44篇 |
1974年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
《中国现代医生》2020,58(11):135-138
目的 探讨齐拉西酮和奥氮平对于治疗早期精神分裂症的临床疗效及比较两者的安全性。方法 选取我院2017年9月~2019年2月收治的60例早期精神分裂症患者作为研究对象,采用数字随机法将所有患者分成对照组30例和观察组30例,对照组给予奥氮平治疗,观察组给予齐拉西酮治疗。2周为1个疗程,两组均进行8周4个疗程治疗。比较两组患者于治疗前和治疗后2、4、8周进行阳性和阴性症状量表(PANNS)评分,病情严重程度(SI)、疗效总评(GI)评分和不良反应。结果 治疗2周、4周后,两组患者的PANSS评分和SI、GI评分均较低于治疗前,但两组的PANSS评分和SI、GI评分比较,差异无统计学意义(P0.05);疗程结束后,观察组的患者PANSS评分和SI、GI评分均低于对照组,差异有统计学意义(P0.05);治疗期间,对照组的不良反应发生率高于观察组,差异有统计学意义(P0.05)。结论 对于治疗早期分裂症患者,齐拉西酮的长期治疗效果明显优于奥氮平,且安全可靠,值得临床上进一步推广。 相似文献
2.
Alexander C. Egbe Rosalyn Adigun Vidhu Anand Collin P. West Victor M. Montori Hassan M. Murad Emmanuel Akintoye Karim Osman Heidi M. Connolly 《The Canadian journal of cardiology》2019,35(12):1784-1790
BackgroundAlthough there are robust data about the pathophysiology and prognostic implications of left ventricular (LV) systolic dysfunction in patients with acquired heart disease, similar prognostic data about LV systolic dysfunction are sparse in the tetralogy of Fallot (TOF) population. The purpose of this study was to perform a meta-analysis of all studies that assessed the relationship between LV ejection fraction (LVEF) and cardiovascular adverse events (CAEs) defined as death, aborted sudden death, or sustained ventricular tachycardia.MethodsWe used random-effects models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs).ResultsOf the 1,809 citations, 7 studies with 2,854 patients (age 28 ± 4 years) were included. During 5.6 ± 3.4 years' follow-up, there were 82 deaths, 17 aborted sudden cardiac deaths, and 56 sustained ventricular tachycardia events. Overall, CAEs occurred in 5.1% (144 patients). As a continuous variable, LVEF was a predictor of CAE (HR 1.29, 95% CI, 1.09-1.53, P = 0.001) per 5% decrease in LVEF. Similarly, LVEF < 40% was also a predictor of CAE (HR 3.22, 95% CI, 2.16-4.80, P < 0.001).ConclusionsLV systolic dysfunction was an independent predictor of CAE, and we observed a 30% increase in the risk of CAE for every 5% decrease in LVEF, and a 3-fold increase in the risk of CAE in patients with LVEF <40% compared with other patients. These findings underscore the importance of incorporating LV systolic function in clinical risk stratification of patients with TOF and the need to explore new treatment options to address this problem. 相似文献
3.
4.
5.
6.
《Journal de gynecologie, obstetrique et biologie de la reproduction》2015,44(5):411-418
7.
Schizophrenia is a chronic and severe psychiatric disorder that has profound impact on an individual’s life and on society. Thus, developing more effective therapeutic interventions is essential. Over the past quarter‐century, an abundance of evidence from pharmacologic challenges, post‐mortem studies, brain imaging, and genetic studies supports the role of glutamatergic dysregulation in the pathophysiology of schizophrenia, and the results of recent randomized clinical trials based on this evidence have yielded promising results. In this article, we review the evidence that alterations in glutamatergic neurotransmission, especially focusing on the N‐methyl‐d ‐aspartate receptor (NMDAR) function, may be a critical causative feature of schizophrenia, how this contributes to pathologic circuit function in the brain, and how these insights are revealing whole new avenues for treatment development that could reduce treatment‐resistant symptoms, which account for persistent disability. 相似文献
8.
9.
目的探讨对慢性支气管炎急性发作期患者采用盐酸氨溴索联合多索茶碱治疗的临床疗效。方法选取本院收治的慢性支气管炎急性发作期患者88例为研究对象,收治时间为2018年3月-2019年3月,根据入院时间将患者随机分为两组,对照组(n=44)和观察组(n=44)。观察组患者采用盐酸氨溴索联合多索茶碱治疗,对照组采用多索茶碱治疗,对两组患者治疗后的治疗有效率以及两组患者症状改善情况进行观察比较。结果观察组患者治疗有效率(97.7%)高于对照组(84.1%),P <0.05;观察组患者症状改善情况优于对照组,P <0.05。结论盐酸氨溴索联合多索茶碱治疗慢性支气管炎急性发作期患者,临床疗效较好,改善患者症状情况。 相似文献
10.
《Clinical neurophysiology》2019,130(2):297-302
ObjectiveTo assess the diagnostic performance of electrophysiology and nerve ultrasound in ulnar neuropathies of varying clinical severity in 135 consecutive patients.MethodsClinical severity of ulnar neuropathy was graded on a 4 point scale from very mild (symptoms only) to severe (marked atrophy of intrinsic hand muscles). Sensitivity and localization ability of electrophysiology and nerve ultrasound were assessed for each point of the scale.ResultsUltrasound had higher sensitivity than electrophysiology in clinically very mild (20% and 3% for ultrasound and electrophysiology, respectively) and mild (62% and 47% for ultrasound and electrophysiology, respectively) neuropathies, had greater localizing ability in axonal ulnar neuropathies, and identified nerve hypermobility.Ultrasound nerve cross-sectional area had strong positive correlation with both clinical and electrophysiological severity scores, but with significant overlap across the severity groups.ConclusionThe diagnostic work-up of ulnar neuropathies was improved by using both electrophysiology and ultrasound at all levels of clinical severity. Ultrasound increased the diagnostic yield in very mild and mild neuropathies, localized all the ulnar neuropathies with abnormal non-localizing electrophysiology and identified nerve hypermobility.SignificanceThis is the first detailed analysis of the diagnostic performance of electrophysiology and ultrasound in ulnar neuropathies of varying severity. 相似文献